| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MORF | Common Stock | Options Exercise | $43,200 | +10,000 | +8.6% | $4.32* | 126,192 | 14 Feb 2023 | Direct | |
| transaction | MORF | Common Stock | Sale | $400,901 | -10,000 | -7.9% | $40.09 | 116,192 | 14 Feb 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MORF | Stock Option (right to buy Common Stock) | Options Exercise | $0 | -10,000 | -6.8% | $0.000000 | 138,114 | 14 Feb 2023 | Common Stock | 10,000 | $4.32 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| F2 | The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. |